0.71
price down icon0.21%   -0.0015
 
loading
Schlusskurs vom Vortag:
$0.7115
Offen:
$0.705
24-Stunden-Volumen:
77,056
Relative Volume:
0.49
Marktkapitalisierung:
$27.70M
Einnahmen:
$135.87M
Nettoeinkommen (Verlust:
$72.20M
KGV:
0.50
EPS:
1.42
Netto-Cashflow:
$45.09M
1W Leistung:
-6.58%
1M Leistung:
-3.30%
6M Leistung:
-33.02%
1J Leistung:
-66.59%
1-Tages-Spanne:
Value
$0.705
$0.7257
1-Wochen-Bereich:
Value
$0.7008
$0.79
52-Wochen-Spanne:
Value
$0.66
$2.28

Scynexis Inc Stock (SCYX) Company Profile

Name
Firmenname
Scynexis Inc
Name
Telefon
201-884-5485
Name
Adresse
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Name
Mitarbeiter
29
Name
Twitter
@scynexis
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
SCYX's Discussions on Twitter

Vergleichen Sie SCYX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
SCYX
Scynexis Inc
0.71 29.66M 135.87M 72.20M 45.09M 1.42
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.19 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.55 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.89 13.23B 2.99B 1.21B 1.13B 25.06

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-01-22 Eingeleitet Guggenheim Buy
2021-01-06 Eingeleitet Cantor Fitzgerald Overweight
2018-07-11 Hochstufung Needham Hold → Buy
2018-06-27 Eingeleitet Maxim Group Buy
2017-10-24 Eingeleitet Guggenheim Buy
2017-07-10 Eingeleitet ROTH Capital Buy
2017-05-09 Herabstufung Needham Buy → Hold
2017-03-03 Bestätigt RBC Capital Mkts Outperform
2016-10-20 Eingeleitet H.C. Wainwright Buy
2016-10-07 Hochstufung WBB Securities Buy → Strong Buy
2016-10-03 Fortgesetzt Brean Capital Buy
2016-08-17 Eingeleitet Guggenheim Buy
2016-08-09 Bestätigt Needham Buy
2016-08-09 Hochstufung WBB Securities Speculative Buy → Buy
2016-03-28 Eingeleitet Brean Capital Buy
2015-12-29 Eingeleitet WBB Securities Speculative Buy
2015-11-16 Bestätigt RBC Capital Mkts Outperform
2015-06-10 Eingeleitet Needham Buy
2014-05-29 Eingeleitet Canaccord Genuity Buy
2014-05-29 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Scynexis Inc Aktie (SCYX) Neueste Nachrichten

pulisher
05:45 AM

What drives SCYNEXIS Inc. stock priceAccelerated wealth building - Autocar Professional

05:45 AM
pulisher
04:28 AM

SCYNEXIS Inc. Stock Analysis and ForecastFast-track wealth growth - Autocar Professional

04:28 AM
pulisher
Jul 22, 2025

What analysts say about SCYNEXIS Inc. stockUnmatched profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is SCYNEXIS Inc. a good long term investmentRobust financial gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Is ATH.PRA a good long term investmentSkyrocketing returns - Jammu Links News

Jul 19, 2025
pulisher
Jul 16, 2025

What makes SCYNEXIS Inc. stock price move sharplyTop Analyst Picks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why SCYNEXIS Inc. stock attracts strong analyst attentionGrowth Stock Monitor - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How SCYNEXIS Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Scynexis Inc (SCYX) Stock: A Year of Highs and Lows in the Market - investchronicle.com

Jul 15, 2025
pulisher
Jul 02, 2025

SCYNEXIS Holds Annual Meeting, Re-elects Directors - The Globe and Mail

Jul 02, 2025
pulisher
Jun 26, 2025

SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price - TipRanks

Jun 26, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 15, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Buys New Holdings in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

Bright Minds Biosciences (NASDAQ:DRUG) & SCYNEXIS (NASDAQ:SCYX) Head-To-Head Survey - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Biosergen taps antifungal expert as board member - Biostock

Jun 05, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Has $186,000 Stake in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 03, 2025
pulisher
May 29, 2025

Scynexis resumes dosing in Phase III MARIO study after lengthy delay - MSN

May 29, 2025
pulisher
May 29, 2025

SCYNEXIS resumes Phase 3 antifungal study after FDA lift By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA Hold - Insider Monkey

May 29, 2025
pulisher
May 28, 2025

Scynexis resumes patient dosing in Phase 3 MARIO study - TipRanks

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing In Phase 3 MARIO Study - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX St - GuruFocus

May 28, 2025
pulisher
May 28, 2025

GSK Involved in SCYNEXIS's Phase 3 Study Milestone Dispute | GSK Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS resumes Phase 3 antifungal study after FDA lift - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study - The Manila Times

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Restarts Critical Phase 3 Trial for Life-Threatening Infection, Faces $30M GSK Payment Battle - Stock Titan

May 28, 2025
pulisher
May 19, 2025

SCYNEXIS Faces Challenges Amidst Antifungal Developments - TipRanks

May 19, 2025
pulisher
May 16, 2025

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval - Endpoints News

May 16, 2025
pulisher
May 16, 2025

SCYNEXIS (NASDAQ:SCYX) Now Covered by Analysts at StockNews.com - Defense World

May 16, 2025
pulisher
May 16, 2025

SCYNEXIS Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 16, 2025

Scynexis: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

May 16, 2025

Finanzdaten der Scynexis Inc-Aktie (SCYX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$72.34
price up icon 1.09%
$14.93
price up icon 1.70%
$9.24
price up icon 3.82%
drug_manufacturers_specialty_generic RDY
$14.41
price down icon 0.96%
$132.75
price up icon 0.70%
$297.89
price up icon 1.63%
Kapitalisierung:     |  Volumen (24h):